Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...

A new study in Nature shows that delivering a single injection of gene therapy at birth may offer years-long protection ...

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

AAV gene therapy in early life provides lasting HIV protection in primates—offering hope for pediatric HIV intervention in ...

Globally, an estimated 1.3 million women and girls living with HIV become pregnant every year, according to the World Health ...

Despite national commitments and visible progress in the fight against HIV/AIDS, Nigeria continues to grapple with high rate ...

Modupe O. Coker from the School of Dental Medicine and a collaborative team of researchers identified changes over time in ...

This month, the Substance Abuse and Mental Health Services Administration (SAMHSA) announced a $100 million pilot program ...

A new study in Nature shows that delivering a single injection of gene therapy at birth may offer years-long protection ...

GSK, led by boss Emma Walmsley (pictured), saw revenues rise 5% to £15.5bn in the first half of the year and profits were up ...